-
School of Nursing’s Special Relationship with MedStar Health Enhances Students’ Clinical Experiences
Georgetown University and MedStar Health’s academic health system partnership translates into valuable clinical learning experiences for students at the School of Nursing and a robust pipeline of Georgetown-educated nurses for MedStar Health hospitals. MedStar Health is the largest not-for-profit health system in the region; its flagship hospital, MedStar Georgetown University Hospital, is located just steps from the school.
Category: GUMC Stories
-
At 36th Annual Lombardi Gala, Friends Help Push Boundaries
A community of nearly 500 new and longtime friends donned gowns and black ties for the 36th annual Lombardi Gala, the largest continuous fundraising event for Georgetown’s Lombardi Comprehensive Cancer Center.
Category: GUMC Stories
-
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Category: News Release
-
New Study: Analysis Supports New Recommendation to Begin Mammogram Screening at 40
Georgetown Lombardi’s Jeanne Mandelblatt, MD, MPH, and Amy Trentham-Dietz, PhD, of University of Wisconsin Carbone Cancer Center, were lead authors of a study informing the updated final recommendation of the United States Preventive Services Task Force regarding breast cancer screening, released April 30
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Psychosocial Oncology Program Promotes Cura Personalis in Cancer Care
As director of the psychosocial oncology program at Georgetown Lombardi, Kimberly M. Davis, PhD, supports the psychological needs of cancer patients, while also training future independent clinical researchers in the field.
Category: GUMC Stories
-
Global Health Alum Transforms Cambodian River Waste into Sustainable Fashion
Alyssa Erin Kardos Loera (NHS’21) credits her Georgetown experience with preparing her for her current role as CEO of ReMade in Cambodia, which she founded while serving as a Fulbright English teaching assistant in that country. Working with local young designers, the enterprise collects and then transforms textile river waste into sustainable wearable products.
Category: GUMC Stories
-
Record Number of Students Share Research at Annual Undergraduate Research Conference
A record 94 Georgetown students from diverse majors such as biology, nursing, chemistry, psychology, and the human sciences presented their work at this year’s Undergraduate Research Conference, which took place during a daylong poster session on Wednesday, April 17, in the Healey Family Student Center.
Category: GUMC Stories
-
Georgetown Hires Norman Beauchamp as New Executive Vice President of Health Sciences
Georgetown has selected Dr. Norman J. Beauchamp, a higher education leader in health sciences, a clinical researcher and a radiologist who has advanced the treatment of stroke, as the new executive vice president for health sciences at Georgetown University Medical Center (GUMC) and executive dean of Georgetown University School of Medicine.
Category: GUMC Stories
-
A Third of Women Experience Migraines Associated with Menstruation, Most Commonly When Premenopausal
A third of the nearly 20 million women who participated in a national health survey reported migraines during menstruation, and of them, 11.8 million, or 52.5%, were premenopausal. The analysis was conducted by researchers at Georgetown University Medical Center and Pfizer, Inc., which makes a migraine medication.
Category: News Release
